Sharemaestro Newsreel

Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Heartbeam Inc (BEAT), detailing its support, resistance, indicators, and moving averages. It includes a summary of various technical indicators like MACD, RSI, and KDJ, alongside moving average data for different periods. The analysis concludes with a neutral …

VSee Health, Inc. signed a letter of intent to acquire Certain healthcare technology and operating assets.

VSee Health, Inc. signed a letter of intent to acquire certain healthcare technology and operating assets on July 29, 2026. This acquisition is pending regulatory approval, a due diligence investigation, and a definitive agreement. The company focuses on virtual care solutions through an API-driven …

10x Genomics Inc Class A Revenue Breakdown – GETTEX:1KJ

This article details the revenue breakdown for 10x Genomics Inc Class A (GETTEX:1KJ). In the last fiscal year, the company generated 547.31 million EUR, with the Consumables - Single Cell segment contributing the most at 309.24 million EUR. The United States was the largest …

Spok: Q2 Earnings Snapshot

Spok Holdings Inc. (SPOK) reported a profit of $4.1 million, or 20 cents per share, in its second quarter. The communications services provider also announced revenue of $35 million for the period. Spok projects its full-year revenue to be in the range of $132.5 …

So-Young International Inc (SY) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of So-Young International Inc (SY), noting its current valuation score of 6.59 within the Software & IT Services industry. The company's P/E ratio is -5.67, with P/E, P/B, and P/S relevant data not fully disclosed.

Law firm investigates Phreesia directors for possible breaches of fiduciary duty

Bernstein Liebhard LLP is investigating whether Phreesia, Inc.'s directors and officers breached their fiduciary duties to shareholders. The investigation seeks to determine if the company's leadership acted in the best interests of shareholders and if legal action against them is warranted. Shareholders who purchased …

Omnicell earnings on deck: Can Titan XT launch sustain momentum?

Omnicell Inc. is set to report its second-quarter results, with analysts anticipating earnings of 47 cents per share on revenue of $310.25 million. Investors will be focused on the performance and adoption rates of the newly launched Titan XT cabinet system, which is seen …

OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET

OptimizeRx will host a conference call on Wednesday, August 12, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the second quarter ended June 30, 2026. Financial results will be released via press release before the call, which will include a …

VSee Health’s Proposed $42M Acquisition Could Add $35M Annualized Revenue

VSee Health (NASDAQ: VSEE) has entered into a non-binding letter of intent to acquire healthcare technology and operating assets valued at approximately $42 million. These assets, which support a vertically integrated healthcare commerce platform, are reported to have an unaudited annual revenue run rate …

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

This article identifies 12 healthcare stocks experiencing significant movement in Wednesday's pre-market session. It lists both gainers, such as Autonomix Medical and OneMedNet, with notable percentage increases and mentions their market capitalization. The article also highlights decliners, including Processa Pharmaceuticals and China SXT Pharmaceuticals, …

Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026

Health Catalyst, Inc. (Nasdaq: HCAT) will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. The company will also host a conference call to discuss these results at 5:00 pm ET on the same day. Details for accessing …

Management will take questions after OptimizeRx releases Q2 results

OptimizeRx (Nasdaq: OPRX) has announced it will host a conference call on Wednesday, August 12, 2026, at 4:30 p.m. ET to discuss its financial results for the second quarter ended June 30, 2026. The results will be released in a press announcement prior to …

Onemednet Corp (ONMD) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Onemednet Corp. (ONMD), detailing its current risk score, industry ranking, and beta value. It further breaks down various risk metrics including maximum drawdown, volatility, Sharpe ratio, and liquidity indicators. The assessment notes the neutral effect of the …

Certara Number of Employees 2026 | Employee Count & Headcount Data

Certara, Inc. (CERT) has approximately 1,618 total employees worldwide as of March 2026, representing a 4.9% growth from 1,542 employees in 2023. The company is actively hiring, although job postings have declined by 19.4% in 2026 compared to 2025. Certara's workforce is concentrated in …

Lazard Asset Management LLC Sells 9,893 Shares of HealthEquity, Inc. $HQY

Lazard Asset Management LLC recently reduced its stake in HealthEquity, Inc. ($HQY) by selling 9,893 shares, bringing its total holdings to 341,399 shares valued at $28.53 million. Several other institutional investors also adjusted their positions in the company. HealthEquity has a consensus "Moderate Buy" …

Teladoc Health (TDOC) Stock Still Looks Undervalued After a 94% Five Year Fall

Teladoc Health (TDOC) stock appears undervalued despite a significant 94% decline over the past five years. Both Discounted Cash Flow (DCF) analysis and market multiples suggest upside potential, with the DCF model indicating a 37.0% discount to intrinsic value. The company's future hinges on …

HealthEquity, Inc. $HQY Shares Bought by Public Employees Retirement System of Ohio

The Public Employees Retirement System of Ohio increased its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 23.4% in the first quarter, now owning 77,914 shares valued at $6.51 million. Several other institutional investors also adjusted their positions in HQY, and the stock currently holds an …

Certara, Inc. (CERT) Stock Analysis: A Healthcare Investment With Limited Upside Potential

Certara, Inc. (CERT) is a significant player in the health information services industry, offering biosimulation solutions for drug discovery and clinical research. Despite its innovative technology and robust free cash flow, the company is not currently profitable, with negative EPS and return on equity. …

EverSource Wealth Advisors LLC Has $5.51 Million Stock Holdings in HealthEquity, Inc. $HQY

EverSource Wealth Advisors LLC increased its stake in HealthEquity (NASDAQ:HQY) by 21.2% in the first quarter, now holding 65,890 shares valued at $5.51 million. Institutional investors own 99.55% of the company, which recently reported strong quarterly earnings, exceeding analyst expectations with EPS of $1.24 …

Heartflow Inc (HTFL) Risk Assessment: Volatility, Financial Risk & Investment Risk

Heartflow Inc (HTFL) has a current risk assessment score of 4.14, placing it 106th out of 199 companies in the Healthcare Equipment & Supplies industry. The stock's beta value of 0.00 suggests it tends to underperform in rising markets but experiences smaller declines in …

CARL|Carlsmed Ord Shs|Price:12.330|Chg%:+0.880

This article provides a detailed financial overview of Carlsmed Ord Shs (CARL), including its current stock price, market capitalization, and key financial figures. It highlights analyst ratings, with 5 analysts recommending "Buy" and a target price of $18.60, indicating a 62.45% upside. The article …

NRC|National Research Corp|Price:22.290|Chg%:+1.020

This article provides a comprehensive stock analysis of National Research Corp (NRC) according to TradingKey's scoring system. It highlights NRC's stable fundamentals, high growth potential, and fair valuation within the Professional & Commercial Services industry. The analysis also notes high institutional ownership and a …

OneMedNet Stock Rallies 33% After Hours: Here's Why

OneMedNet (NASDAQ: ONMD) shares surged 33% after hours following the announcement of an $11.5 million agreement to provide its iRWD™ imaging data platform for foundational AI model training. This deal validates the company's ability to deliver regulatory decision-grade Real-World Data at scale. The company's …

Tempus AI Posts Strong Q2 Results, Raises 2026 Outlook

Tempus AI (TEM) reported strong second-quarter 2026 results with revenue up 22% year-over-year to $382.5 million and gross profit up 26%, driven by growth in oncology diagnostics and data licensing. The company achieved GAAP net income and improved adjusted EBITDA, while also announcing the …

Mangoceuticals Inc (MGRX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Mangoceuticals Inc (MGRX), noting its current valuation score of 9.10, which ranks 19th in the Healthcare Providers & Services industry. It states the company's P/E ratio is -0.42 but highlights that relevant data for P/B, P/S, and …

HealthEquity, Inc. Revenue Breakdown – NASDAQ:HQY

HealthEquity, Inc. (NASDAQ: HQY) generated $1.31 billion USD in revenue last year. The "Custodial" segment was the top-performing segment, contributing $636.80 million USD, an increase from $545.41 million USD the previous year. The United States was the primary geographic contributor, accounting for all of …

Spok Holdings (SPOK) Q2 Earnings and Revenues Surpass Estimates

Spok (NASDAQ:SPOK) Releases Earnings Results, Beats Expectations By $0.05 EPS

LifeMD (LFMD) Projected to Announce Quarterly Earnings on Wednesday

Will Carlsmed, Inc. (CARL) Report Negative Earnings Next Week? What You Should Know

Teladoc (NYSE:TDOC) Misses Q2 CY2026 Revenue Estimates, Stock Drops 24.1%

Teladoc Lowers BetterHelp Outlook After Cash-Pay Revenue Falls

Teladoc (TDOC) Reports Q2 Loss, Lags Revenue Estimates

Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Teladoc Health (TDOC) Releases Q2 2026 Earnings: Revenue Misses Estimates but EPS Improves

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, missing estimates, while its net loss of $(0.21) per diluted share improved compared to the prior year and beat estimates. The company's financials also detail insider trading activity with 18 sales and no purchases …

GoodRx (GDRX) Expected to Release Earnings on Wednesday